1. CONSOLIDATION THERAPY USING 90Y‐IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012). (12th June 2019) Authors: Kanno, M.; Miura, K.; Masaki, Y.; Tsujimura, H.; Iino, M.; Takizawa, J.; Maeda, Y.; Yamamoto, K.; Tamura, S.; Yoshida, A.; Yagi, H.; Yoshida, I.; Kitazume, K.; Masunari, T.; Choi, I.; Kakinoki, Y.; Suzuki, R.; Yoshino, T.; Nakamura, S.; Yoshida, T. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗